Categories AlphaGraphs, Earnings, Finance

Earnings: Here’s everything you need to know about BOK Financial’s Q1 2023 results

BOK Financial Corporation (NASDAQ: BOKF) has reported an increase in net interest revenue for the first quarter of 2023 when the financial service company’s earnings more than doubled.

BOK Financial Corporation Q1 2023 earnings infographic

In the first three months of fiscal 2023, net income more than doubled to $162.4 million or $2.43 per share from $62.5 million or $0.91 per share in the comparable period of the prior year. Driving the bottom-line growth, net interest revenue climbed 31% annually to $352.3 million. Net interest margin was 3.45% in Q1, compared to 2.44% in the first quarter of 2022.

At the end of March 2023, total loans were $22.8 billion, compared to $20.7 billion in the same period of the prior year. The company’s tangible common equity ratio, excluding special items, was 8.46% at the end of the quarter.

“The strong financial results in the first quarter are a testament to our diverse business model, strong operating geographies, and disciplined approach to risk management that has long been critical to our ability to sustain success. Our peer-leading tangible capital ratio paired with our balance sheet liquidity have served us well over the last 45 days with the disruptions in our sector,” said BOK’s chief executive officer Stacy Kymes.

Prior Performance

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top